CUSIP: 31572Q808
Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
100,740,741
-
Total 13F shares
-
45,933,468
-
Share change
-
-10,332,256
-
Total reported value
-
$18,857,141
-
Put/Call ratio
-
191%
-
Price per share
-
$0.40
-
Number of holders
-
68
-
Value change
-
-$6,430,829
-
Number of buys
-
19
-
Number of sells
-
68
Quarterly Holders Quick Answers
What is CUSIP 31572Q808?
CUSIP 31572Q808 identifies FGEN - FIBROGEN INC - Common Stock, $0.01 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2024
-
Previous quarter:
Q2 2024
Recent filing periods for CUSIP 31572Q808:
Institutional Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q3 2024
As of 30 Sep 2024,
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) was held by
68 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
45,933,468 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, BlackRock, Inc., 683 Capital Management, LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, JPMORGAN CHASE & CO, MARSHALL WACE, LLP, and GSA CAPITAL PARTNERS LLP.
This page lists
68
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.